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The packaging of DNA into chromatin plays an important role in transcriptional regulation and nuclear processes. Brahma-
related gene-1 SMARCA4 (also known as BRG1), the essential ATPase subunit of the mammalian SWI/SNF chromatin re-
modeling complex, uses the energy from ATP hydrolysis to disrupt nucleosomes at target regions. Although the transcrip-
tional role of SMARCA4 at gene promoters is well-studied, less is known about its role in higher-order genome
organization. SMARCA4 knockdown in humanmammary epithelial MCF-10A cells resulted in 176 up-regulated genes, includ-
ing many related to lipid and calcium metabolism, and 1292 down-regulated genes, some of which encode extracellular ma-
trix (ECM) components that can exert mechanical forces and affect nuclear structure. ChIP-seq analysis of SMARCA4
localization and SMARCA4-bound super-enhancers demonstrated extensive binding at intergenic regions. Furthermore,
Hi-C analysis showed extensive SMARCA4-mediated alterations in higher-order genome organization at multiple resolu-
tions. First, SMARCA4 knockdown resulted in clustering of intra- and inter-subtelomeric regions, demonstrating a novel
role for SMARCA4 in telomere organization. SMARCA4 binding was enriched at topologically associating domain
(TAD) boundaries, and SMARCA4 knockdown resulted in weakening of TAD boundary strength. Taken together, these find-
ings provide a dynamic view of SMARCA4-dependent changes in higher-order chromatin organization and gene expres-
sion, identifying SMARCA4 as a novel component of chromatin organization.
[Supplemental material is available for this article.]
Organization of chromatin is essential formanybiological process-
es. Packaging of the DNA around the nucleosomes acts to tightly
condense the genome (Cutter and Hayes 2015). At the same
time, the cell has to regulate the accessibility of the chromatin to
many enzymes for the regulation of gene expression, DNA replica-
tion, and repair. Maintaining a balance between tight packaging
and accessibility of the chromatin is an important function of
the eukaryotic nucleus. This balance is achieved by multiple spe-
cialized protein complexes that dynamically alter chromatin struc-
ture in an ATP-dependent manner (Clapier and Cairns 2009). Four
families of ATP-dependent chromatin remodelers exist: SWI/SNF,
ISWI, INO80, and CHD (for review, see Varga-Weisz 2001; Flaus
and Owen-Hughes 2011). The ATPase subunits of each family
have a conserved helicase-like ATPase domain that uses the energy
from ATP hydrolysis to evict, reposition, or modify nucleosomes
(Sala et al. 2011; Narlikar et al. 2013). Different families of remod-
elers work in cells in a dynamic and orchestrated way to fine tune
DNA accessibility (Morris et al. 2014).
The mammalian mating-type switching and sucrose non-
fermenting (SWI/SNF) complexes contain one of two distinct
ATPase subunits, SMARCA2 (also known as Brahma [BRM]) or
SMARCA4 (Muchardt and Yaniv 1993; Wang et al. 1996).
SMARCA2 is thought to be dispensable, as SMARCA2 null mice
can properly develop to adulthood (Reyes et al. 1998), although
this finding has recently been questioned (Thompson et al.
2015). On the other hand, SMARCA4 is essential, as SMARCA4
null mice are embryonic lethal, and SMARCA4 heterozygous
mice show developmental defects and are prone to mammary tu-
mor formation (Bultman et al. 2000, 2008). SMARCA4 has been
shown to be involved in many developmental processes and in
transcriptional regulation, DNA repair, cell cycle control, and can-
cer (Trotter and Archer 2008; King et al. 2012). The role of
SMARCA4 in gene regulation is contextual, as it can activate
some promoters while repressing others. In addition, extensive
dysregulation and mutations of SMARCA4 have been implicated
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inmanydifferent cancer types,making SMARCA4 a potential ther-
apeutic target for cancer (Kadoch et al. 2013; Shain and Pollack
2013).
Through interactions with many different protein partners,
SMARCA4 is involved in nuclear structure and inmediating specif-
ic long-range chromatin interactions (Trotter and Archer 2008;
Euskirchen et al. 2011; Imbalzano et al. 2013a). The organization
of chromatin occurs in a hierarchical manner. Chromosomes are
positioned indistinct volumes forming the chromosometerritories
(Cremer et al. 2006), which consist of open (A-type) and closed (B-
type) genomic compartments (Lieberman-Aiden et al. 2009). The
genomic compartments are further folded into sub-megabase-
scaled structures called topologically associating domains (TADs)
(Dixon et al. 2012; Nora et al. 2012, 2013), where local looping in-
teractions between promoters and enhancers occur (Sanyal et al.
2012; Symmons et al. 2014; Tang et al. 2015; Smith et al. 2016).
SMARCA4 regulates inter-chromosomal interactions between
tissue-specific promoters during myogenesis (Harada et al. 2015)
and is required for looping at many gene loci, including the beta
and alpha-globin genes (Kim et al. 2009a,b), the IgH locus
(Bossen et al. 2015), and the class II major histocompatibility com-
plex gene (CIITA) (Ni et al. 2008). SMARCA4 binds to poised devel-
opmental enhancers in embryonic stem cells (Hu et al. 2011; Rada-
Iglesias et al. 2011) and B-cells (Bossen et al. 2015) and colocalizes
with pluripotency factors (Ho et al. 2009), suggesting important
roles in enhancer function. Furthermore, previouswork classifying
genome-wide interactions according to their histone modifica-
tions and transcription factor binding revealed SMARCA4 enrich-
ment at open chromatin regions, indicating a possible structural
role for SMARCA4 (Lan et al. 2012). In addition, SMARCA4 knock-
down affects nuclear size (Hill et al. 2004) and the integrity of
nuclear shape via a mechanism independent of cytoskeletal con-
nections (Imbalzano et al. 2013b). Recently, SMARCA4was shown
to be involved in the lncRNA-dependent assembly of nuclear bod-
ies (Kawaguchi et al. 2015).
Taken together, apart from its chromatin remodeling activity
at the regulatory regions of target genes, emerging evidence sug-
gests a possible important role for SMARCA4 in maintaining the
structural integrity of the nucleus by regulating global chromatin
structure (Imbalzano et al. 2013a). To date, very little is known
about the role of SMARCA4 in global higher-order genome organi-
zation. To gain insight into the role of SMARCA4 in nuclear orga-
nization at a genome-wide level, we performed RNA-seq and Hi-C
in SMARCA4-knockdown and controlMCF-10Ahumanmammary
epithelial cells. Furthermore, to map the localization of SMARCA4
in the genome, we performed SMARCA4 ChIP-seq in the parental
MCF-10A cells. Overall, we show that SMARCA4 knockdown is as-
sociated with extensive changes in gene expression and higher-or-
der chromatin structure, affecting TAD boundaries and telomere
clustering.
Results
SMARCA4 globally affects gene regulation in MCF-10A cells
To investigate the roles of SMARCA4 in transcriptional regula-
tion, we used previously described doxycycline-inducible MCF-
10A mammary epithelial cells expressing either a nonspecific
(scrambled) shRNA (shSCRAM), or shRNA against SMARCA4
(shSMARCA4) (Cohet et al. 2010). We confirmed the down-regula-
tion of the SMARCA4 protein by Western blot analysis in doxycy-
cline-induced cells (Fig. 1A).
Next, we performed poly(A) RNA-seq in doxycycline-induced
shSMARCA4 and shSCRAM MCF-10A cells (Supplemental Figs.
S1A–E, S2A,B).We identified 176 up-regulated and 1292 down-reg-
ulated genes upon SMARCA4 knockdown (Fig. 1B,C; Supplemental
Table S1). REACTOME pathway analysis (Milacic et al. 2012; Croft
et al. 2014) of down-regulated genes identified pathways related to
“extracellular matrix (ECM) organization,” “collagen degrada-
tion,” “cell adhesion molecule L1-like (CHL1) interactions,” and
“cohesin loading onto chromatin” (Fig. 1D). A significant number
of these genes were associated with cell adhesion, including many
proteoglycans, integrins, and laminins. This result suggests a role
for SMARCA4 in ECM biology and nuclear structure. On the other
hand, up-regulated genes were associated with calcium signaling
and lipid metabolism, including pathways related to “regulation
of cholesterol biosynthesis by SREBP,” “fatty acids,” and “eicosa-
noids,” which are the byproducts of fatty acid oxidation (Fig. 1E).
Furthermore, we assessed the transcriptional changes of poly-
adenylated long noncoding RNAs (lncRNAs) using the GENCODE
v19 lncRNA gene annotation (Trapnell et al. 2013). We identified
88 down-regulated and 64 up-regulated poly(A) lncRNAs upon
SMARCA4 knockdown (Supplemental Table S2). This suggests a
widespread role of SMARCA4 in the transcriptional regulation of
both coding and noncoding genes. Although the majority of the
differentially expressed lncRNAs were unannotated, we observed
down-regulation of several well-known lncRNA genes, including
XIST, NEAT1, and MALAT1, and up-regulation of the imprinted
lncRNA H19. We validated the RNA-seq results by performing
qRT-PCR on 23 coding and noncoding genes of interest. There
was a significant correlation between qRT-PCR and RNA-seq re-
sults (Spearman’s ρ = 0.65, P = 4.17 × 10−6) (Supplemental Fig.
S2C,D).
Taken together, these results suggest that SMARCA4 positive-
ly regulates genes associated with ECM, supporting the role for
SMARCA4 in ECM biology (Xu et al. 2007; Stankunas et al. 2008;
Saladi et al. 2010), and negatively regulates genes related to lipid
metabolism and calcium signaling in mammary epithelial cells.
Moreover, SMARCA4 also regulates the expression of many
lncRNAs.
SMARCA4 ChIP-seq analysis reveals extensive binding
to intergenic and intronic regions in MCF-10A cells
To confirm that SMARCA4-dependent alterations in gene ex-
pression observed by RNA-seq are directly related to SMARCA4
binding, we performed ChIP-seq analysis in wild-type MCF-10A
cells (Fig. 2; Supplemental Fig. S3A,B). We identified 15,046
SMARCA4 ChIP-seq peaks. The binding profile of SMARCA4 dem-
onstrated that SMARCA4 binds to defined locations in the genome
(Fig. 2A). Annotation of SMARCA4 ChIP-seq peaks revealed that
60% of the binding sites were localized in promoters, introns,
and exons (gene bodies), whereas 40% of the sites were bound to
intergenic regions (Fig. 2B). Consistent with the annotation of
SMARCA4 peaks, normalized SMARCA4 binding signal across all
human genes was highest at promoter regions (Fig. 2C). Because
SMARCA4 was enriched at the promoters, we intersected the
SMARCA4 peaks with a publicly available MCF-10A Pol II ChIP-
seq data set (GSM935588) (The ENCODE Project Consortium
2012) and determined that 27% of all SMARCA4 bound sites
were also bound by Pol II (Supplemental Fig. S3C).
By performing de novomotif analysis on SMARCA4peaks, we
identified enriched motifs for MEF2A/C, USF2, SMAD2/4, TP53,
and SPI1 (Fig. 2D). These factors may be functionally related
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because SMARCA4 is a coregulator for many of these factors.
MEF2C has been shown to interact with SMARCA4 and is required
for the activity-dependent recruitment of SMARCA4 to its target
regions (Zhang et al. 2015). Moreover, USF1/2 can bind a
SMARCA4-associated factor, SMARCD3, and recruit other BAF sub-
units including SMARCA4 (Wang and Sul 1997). In addition,
Figure 1. (A) Western blot of the SMARCA4 protein levels of shSCRAM and shSMARCA4MCF-10A cells in the noninduced (DOX−) and induced (DOX+)
conditions. Lower: Quantification of the Western blot showing ∼85% reduction of SMARCA4 protein levels upon doxycyline induction. (B) Scatter plot
showing the log2 gene expression values for shSMARCA4 and shSCRAM cells. The red and blue dots denote the up- and down-regulated genes between
the two conditions, respectively. (C) Heatmap showing the transcripts per million (TPM) expression values of the differentially expressed genes between
shSCRAM and shSMARCA4 for each biological replicate. (D,E) Bar graphs showing the −log10 P-values for the REACTOME terms of the (D) 1292 genes that
are down-regulated and (E) 176 up-regulated genes upon SMARCA4 knockdown.
Barutcu et al.
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Figure 2. (A) Example of a ChIP-seq genome browser view of SMARCA4 binding and the input control, the shSCRAM and shSMARCA4 RNA-seq on Chr 5,
and a zoom-in on the VCAN (Versican) gene, which is regulated by SMARCA4, in the lower panel. The y-axis represents the normalized tag densities relative
to hg19 genomic coordinates. (B) Distribution of SMARCA4 ChIP-seq peak annotation for genic and intergenic regions. (C ) Normalized SMARCA4 ChIP-
seq signal intensity plot for all human UCSC genes ±2 kb. SMARCA4 binding is enriched at the promoter regions. (D) Top five sequence motifs associated
with the SMARCA4 peaks. (E) SMARCA4 peak density within ±20 kb of the TSS of significantly down-regulated (blue), or up-regulated genes (red). (F)
Distribution of SMARCA4 ChIP-seq signal across the MCF-10A enhancers. SMARCA4 binding is not uniformly distributed across the enhancers, as 109 su-
per-enhancers display higher (log2∼1.5-fold) levels of SMARCA4 binding. (G) SMARCA4 signal is greater over super-enhancers (red) than typical enhancers
(green). (H) Distribution of SMARCA4-bound super-enhancers in genic and intergenic regions.
SMARCA4 regulates chromatin interactions
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SMARCA4 is a direct interaction partner
for SMAD proteins and TP53 (Xi et al.
2008; Naidu et al. 2009).
Next, we asked whether SMARCA4
binding was associated with differen-
tially expressed genes. To address this,
we analyzed the SMARCA4 peak frequen-
cy at the promoters of up- and down-
regulated genes. We observed ∼10-fold
increase in the frequency of SMARCA4
binding at the promoters of genes that
are down-regulated upon SMARCA4
knockdown, whereas there was minimal
association of SMARCA4 with the pro-
moters of genes that are up-regulated
when SMARCA4 is knocked down (Fig.
2E). This result suggests a more direct
role for SMARCA4 in the positive regula-
tion of gene expression inMCF-10A cells.
Recently, super-enhancers, a novel
type of regulatory regions having an un-
usual enrichment of transcription factors
thatare incloseproximity,weredescribed
(Whyte et al. 2013). Super-enhancers are
mostly associated with developmentally
regulated genes. SMARCA4 is localized
at super-enhancers in leukemic and in
normal B-cells (Shi et al. 2013; Bossen
et al. 2015). Using the approach previ-
ously published (Whyte et al. 2013), we
identified 109 SMARCA4-bound super-
enhancers in the MCF-10A genome (Fig.
2F). SMARCA4 signal intensity was great-
er at super-enhancers than at typical
SMARCA4 ChIP-seq peak regions (Fig.
2G). Annotation of the super-enhancers
revealed ∼60% localization at intergenic
regions and ∼40% localization at gene
bodies, but not at promoters (Fig. 2H).
Overall, we identified SMARCA4
binding mostly (60%) at promoters and
gene bodies. In the promoter regions,
there may be individual single (stand-
alone) high-density SMARCA4 peaks,
but since they are not proximal to other
high-density SMARCA4 peaks, they are
not defined as super-enhancers. This result may explain why the
super-enhancers are mostly (60%) enriched at intergenic regions,
whereas the typical SMARCA4 ChIP-seq peaks are mostly (60%)
at promoters and gene bodies. Interestingly, the localization pat-
tern of SMARCA4-bound super-enhancers is opposite of the anno-
tation of typical SMARCA4peaks (intergenic versus promoter) (Fig.
2B), suggesting differential regulatory functions for regular
SMARCA4 peaks and SMARCA4-bound super-enhancers.
Hi-C analysis of SMARCA4 knockdown and control MCF-10A cells
To identify the genome-wide changes in higher-order chromatin
structure following SMARCA4 knockdown, we performed Hi-C
on doxycycline-induced shSCRAM and shSMARCA4 MCF-10A
cells (Fig. 3A,B; Supplemental Table S3). With an average depth
of approximately 115 million reads per biological replicate and
with two biological replicates, we achieved up to 40-kb resolution
genome-wide. The Hi-C heatmaps, which are normalized by total
number of reads, revealed hierarchical higher-order chromatin
structures, such as genomic compartments and TADs, at increasing
resolutions (Fig. 3A,B). There was a high correlation (R2 > 0.90) be-
tween two independent biological replicates at multiple resolu-
tions (Supplemental Fig. S4A–J). The shSCRAM and shSMARCA4
Hi-C data sets exhibited high correlation (R2 > 0.95) with the pre-
viously published wild-type MCF-10A Hi-C data set (Barutcu
et al. 2015). The scaling plot curves of genomic interaction fre-
quencies along genomic distance showed similar trends of decay
and an increase at distances larger than >200 Mb, which we previ-
ously showed to be a characteristic of the MCF-10A genome
(Supplemental Fig. S4C; Barutcu et al. 2015). TheHi-C data sets dis-
played similar cis/trans interaction ratios (an average of ∼25%)
(Supplemental Fig. S4K,L).
Figure 3. Genome-wide all-by-all Hi-C interaction heatmaps at 1-Mb resolution and a zoom-in of Chr
11 at 250-kb resolution (middle) and at 40-kb resolution (lower) in MCF-10A shSCRAM (A) and MCF-10A
shSMARCA4 cells (B). For the genome-wide heatmaps, the chromosomes are stacked from top-left to bot-
tom-right in order (Chr 1, Chr 2,…, Chr 22, and Chr X). The gray regions indicate repetitive regions (such
as centromeres) in which the sequencing reads could not be mapped. The genomic compartments are
shown below the middle heatmaps.
Barutcu et al.
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Genome-wide Hi-C interaction heatmaps showed that, con-
sistent with previous Hi-C studies and the notion of chromosome
territories (Cremer et al. 2006), the intra-chromosomal interac-
tions, which are visualized as dark boxes along the diagonal,
were more frequent than inter-chromosomal interactions (Fig.
3). Moreover, we identified large blocks of inter-chromosomal in-
teractions between Chr 3 and Chr 5, Chr 3 and Chr 9, and Chr 6
and Chr 19, which represent previously known translocations in
the MCF-10A genome (Supplemental Fig. S5; Marella et al. 2009;
Barutcu et al. 2015). Taken together, these analyses reflect the
high quality and reproducibility of the Hi-C data.
SMARCA4 knockdown results in extensive gain and loss
of long-range chromatin interactions and altered telomeric
associations
To map the SMARCA4-mediated alterations in higher-order chro-
matin structure, we compared the genome-wide interactions as
previously described (Fig. 4A; Barutcu et al. 2015; Crane et al.
2015). At multiple resolutions (10-Mb to 40-kb resolution ge-
nome-wide), SMARCA4 knockdown resulted in the disruption of
existing interactions and the emergence of novel specific contacts
throughout each chromosome (Fig. 4B; Supplemental Fig. S6).
Mapping the high-confidence interactions that are depleted/en-
riched upon SMARCA4 knockdown revealed specific regions po-
tentially important for transcriptional regulation (Fig. 4D,E). For
instance, a zoom-in view of the differential interactions at the pro-
moter regions of MALAT1 and NEAT1 lncRNAs, which are down-
regulated upon SMARCA4 knockdown, displayed several differen-
tially interacting regions (Fig. 4D,E).
Although there were several alterations in long-range interac-
tions at high resolution, the positioning of chromosomes relative
to each other was similar following SMARCA4 knockdown (Sup-
plemental Fig. S7A,B). At the chromosomal scale, when only the
significant differential interactions were considered, SMARCA4
knockdown resulted in a higher frequency (Wilcoxon rank-
sum test, P < 1 × 10−180) of trans interactions between the
chromosomes (Supplemental Fig. S7C). Moreover, SMARCA4
knockdown resulted in a lower frequency (Wilcoxon rank-
sum test, P < 1.2 × 10−106) of cis interactions both within and
across the different chromosomal arms on each chromosome
(Supplemental Fig. S7D).
Interestingly, among the subtelomeric regions of the chromo-
somes, we observed a systematic pattern of increased interactions
in shSMARCA4 cells, both in cis and in trans (Fig. 4F). In other
words, the subtelomeric regions of each chromosome displayed
a striking enrichment of interactions with each other upon
SMARCA4 knockdown compared with the shSCRAM control
(Fig. 4F). Quantification of the subtelomeric interactions suggested
a significant increase in both intra- and inter-chromosomal associ-
ations in shSMARCA4 cells compared to shSCRAM (Fig. 4G).
However, this was not the case when interactions in the same re-
gions were randomized (Supplemental Fig. S7E). To validate the
Hi-C results, we performed DNA-FISH by probing the intra-chro-
mosomal telomeric interactions of Chr 1 and Chr 4. Consistent
with our Hi-C findings, SMARCA4 knockdown resulted in a sig-
nificant increase in telomeric proximityof the p and the q chromo-
somal arms of Chr 1 and Chr 4 (Fig. 4H,I). Taken together, these
results indicate a novel role for SMARCA4 in telomere struc-
ture and suggest that disruption of SMARCA4 levels results in
altered three-dimensional organization of telomeric regions of
the genome.
SMARCA4 occupancy is enriched at open compartment regions
Each chromosome territory is composed of megabase-scale geno-
mic compartments that are either A-type (i.e., open, gene rich)
or B-type (i.e., closed, gene poor). The frequency of interactions
within one compartment is greater than the frequency of interac-
tions between compartments (Lieberman-Aiden et al. 2009). We
asked whether SMARCA4 knockdown resulted in any compart-
ment changes. To address this, we binned the genome at 250-kb
nonoverlapping intervals and compared the type of compartmen-
talization for each bin (Fig. 5A). The majority of the compartmen-
talization was similar in shSCRAM and shSMARCA4 MCF-10A
cells, with 42% of the genome consisting of constitutive A-type
compartments and 54%consisting of constitutive B-type compart-
ments (Fig. 5B). Upon SMARCA4 knockdown, a total of 2% of the
genome altered its compartmentalization from A-type to B-type
and 2% showed alteration from B-type to A-type (Fig. 5B).
Compartmentalization of the genome is correlated with gene
expression (Barutcu et al. 2015; Dixon et al. 2015). To understand
the link between compartment switching and gene expres-
sion upon SMARCA4 knockdown, we plotted the shSMARCA4/
shSCRAM log2 fold change RNA-seq expression levels of the genes
that were located either within unchanged compartments or with-
in regions that switched compartments (Fig. 5C). Thegenes located
in regions with a compartment switch fromA-type to B-type upon
SMARCA4knockdownshowedsignificantly lowerexpression levels
than the genes within unaltered compartment regions. The differ-
ences in gene expression within B-type to A-type compartment-
switchingregions(shSMARCA4 toshSCRAM),althoughstatistically
significant (Wilcoxon rank-sum test; P = 0.02), showedmuchmore
similar expression levels upon SMARCA4 knockdown (Fig. 5C).
Nevertheless, theseresults suggestaprominentcorrelationbetween
differential compartmentalization and gene expression.
Next, we asked whether the regions with SMARCA4 binding
were associated with compartment switching. Of all SMARCA4-
bound sites, 76% were located within the constitutive open A-
type compartments. In contrast, 21% of SMARCA4ChIP-seq peaks
were found in the closed B-type compartment regions (Fig. 5D),
and ∼3% of SMARCA4 peaks were in regions showing compart-
ment-switching (Fig. 5D). We then assessed the percentage of
genomic compartment-switching regions that were either bound
or unboundby SMARCA4.Weobserved that SMARCA4was bound
to ∼80% of constitutive A-type compartments (A to A) and ∼50%
of constitutive B-type compartments (B to B) (Fig. 5E). The fre-
quency of SMARCA4 binding to altered compartment regions
was similar, because 75% of “A to B” and 55% of “B to A” compart-
ment-switching regions showed SMARCA4 binding, suggesting a
similar degree of localization at compartment-switching regions.
This suggests that SMARCA4 is therefore not likely to be directly
mediating the compartment switch.
Taken together, these results show that SMARCA4 knock-
down affects compartment organization in the genome.
Although this change is confined to a subset of the genome, it is
associated with differential gene expression.
SMARCA4 is associated with TAD boundaries
and TAD boundary strength
Each compartment is composed of TADs,which are sub-megabase-
scale structures constituting a confined nuclear microenviron-
ment for the proper association and regulation of promoters
and enhancers (Nora et al. 2013). MCF-10A shSCRAM and
shSMARCA4 interaction maps at 40-kb resolution revealed these
SMARCA4 regulates chromatin interactions
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Figure 4. (A) Genome wide interaction heatmap at 2.5 Mb resolution showing the differences between interactions that are gained and lost upon
SMARCA4 knockdown. The chromosomes are stacked from top-left to bottom-right in order (Chr 1, Chr 2, …, Chr 22, and Chr X). (B) A zoom-in of Chr
11 at 250-kb resolution showing all differential interactions. (C) The interactions that are altered with significance (see Methods). (D) A further zoom-in
view of a genomic region on Chr 11 (Chr 11: 60000001–81750000) (top) showing the differential interactions where the MALAT1 and NEAT1 loci reside
(Chr 11: 64750339–65807685). (E) RNA-seq tracks from shSMARCA4 and shSCRAM cells showing a reduction of expression inNEAT1 andMALAT1 lncRNA
genes upon SMARCA4 knockdown. (F) A zoom-in of the inter-chromosomal interactions between Chr 1 and Chr 2 through Chr 5, with arrows indicating
the enriched telomeric interactions in the shSMARCA4 cells. This pattern of subtelomeric interaction occurs throughout the genome. (G) Quantification of
the interactions among subtelomeric ends for shSCRAM and shSMARCA4Hi-C data sets. The subtelomeric ends show significantly (Student’s t-test: P < 0.01
for Chr 1 and P < 0.05 for Chr 4) higher frequency of interactions in shSMARCA4 cells compared to control cells. (H) DNA-FISH images of shSMARCA4 and
shSCRAM cells showing the intra-chromosomal telomeric interactions of Chr 1 and Chr 4. (I) Box plot showing the quantification of the telomere distances
in shSMARCA4 and shSCRAM cells, quantified as described in the methods. P-value: Student’s t-test.
Barutcu et al.
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sub-megabase-scale interaction domains on all chromosomes, sug-
gesting that SMARCA4 knockdown does not result in a loss of TAD
formation (Fig. 6A; Supplemental Fig. S8A,B). In order to quantify
the TAD boundary scores and identify specific TADs, we generated
insulation plots using a method that was described previously
(Barutcu et al. 2015; Crane et al. 2015). We identified 2963 and
2796 TAD boundaries in shSCRAM and shSMARCA4 MCF-10A
cells, respectively (Fig. 6B). The identified TADs showed known
characteristics, such as increased density of genes and Pol II bind-
ing at the boundaries compared to the surrounding regions
(Supplemental Fig. S8C,D). Despite the notion that TADs are stable
across different cell types, species, and different biological contexts
(Dixon et al. 2012, 2015; Nora et al. 2012, 2013), interestingly,
SMARCA4 knockdown altered the localization of ∼14% of the
TAD boundaries. The majority of TAD boundaries (83% of
shSCRAM and 88% of shSMARCA4) were overlapping between
the control and the SMARCA4 knockdown cells (Fig. 6B).
TAD boundaries are bound by proteins such as CTCF and
cohesin in vertebrates (Vietri Rudan et al. 2015) and by several ar-
chitectural binding proteins in flies (Van Bortle et al. 2014).
Therefore, we asked whether SMARCA4 plays any role in TAD
boundaries and assessed whether SMARCA4 localization was en-
riched at TAD boundaries. Intersection of SMARCA4 ChIP-seq
peaks with both the shSMARCA4 and shSCRAM TAD boundary
definitions yielded similar results, in which ∼25% of all
SMARCA4 binding was located at TAD boundaries (Fig. 6C).
Surprisingly, we observed an enrichment of SMARCA4 binding
at the boundaries when the frequency of SMARCA4 binding was
Figure 5. (A) Compartment profiles (the first principal components) of shSCRAM and shSMARCA4 data for Chr 2. The A-type (open) compartments are
shown in black, and the B-type (closed) compartments are shown in gray. The same color scheme was used for the gene density plot for Chr 2 in the lower
panel. (B) Pie chart showing the genomic compartment changes between shSCRAM and shSMARCA4 data sets. “A” and “B” denote the open and closed
compartments, respectively. “A to A” represents compartments that are open in both cell lines; “B to B” represents compartments that are closed in both
cell lines; “A to B” denotes compartments that are open in shSCRAM but closed in shSMARCA4; and “B to A” denotes compartments that are closed in
shSCRAM and open in shSMARCA4. (C) shSMARCA4/shSCRAM log2 fold change RNA-seq expression box plot of all the genes residing at regions for dif-
ferent compartmental switch categories. The compartments that are switched from A to B and from B to A show significantly decreased and increased
expression levels, respectively. P-value: Wilcoxon rank-sum test. (D) Pie chart showing the compartment-switching profiles of SMARCA4-bound regions.
(E) Bar graph showing the percentage of the compartment-switching regions that are bound by SMARCA4. The colored portions of the graph denote the
SMARCA4-bound percentage of each compartment-switching category.
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plotted around the TAD borders (Fig. 6D). Sixty-six percent of all
TAD boundaries were bound by SMARCA4. A similar phenome-
non was observed when SMARCA4-bound super-enhancers were
plotted across the TAD boundaries (Fig. 6E).
The strength of a TAD boundary is ameasure of the allowance
of inter-TAD interactions across the boundary (Van Bortle et al.
2014; Li et al. 2015). Although our data indicate that the majority
of TAD boundaries are similar, we wondered whether SMARCA4
Figure 6. (A) An example of a region on Chr 9 (Chr 9: 103800001–123920000) showing (from top to bottom) the compartment profiles of shSMARCA4
and shSCRAM at 250-kb intervals, the insulation plot profiles at 40-kb intervals (see Methods), the insulation plot difference between shSMARCA4 and
shSCRAM, hg19 UCSC genes, TAD boundaries, shSMARCA4 and shSCRAM contact heatmaps showing the TADs, and a subtraction of the shSCRAM
from the shSMARCA4 contact heatmap. (B) Venn diagram showing that the TAD boundaries are largely similar between shSCRAM and shSMARCA4 Hi-
C data sets. (C) Pie chart showing the percentage of SMARCA4 localization at TAD boundaries. (D) The frequency plot of SMARCA4 ChIP-seq peaks
per 25 kb for ±1 Mb of every shSMARCA4 TAD boundary. (E) The frequency plot of SMARCA4 super-enhancers per 50 kb for ±1 Mb of every
shSMARCA4 TAD boundary. (F) Box plot showing the TAD boundary score distribution for the overlapping and the shSCRAM- and shSMARCA4-specific
TAD boundaries. P-value: Wilcoxon rank-sum test. (G) SMARCA4 binding is associated with higher (Wilcoxon rank-sum test; P = 0.003) TAD boundary
score. Box plot showing the TAD boundary scores for SMARCA4-bound and unbound TAD boundaries.
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knockdown resulted in a change in TAD boundary strength.
Interestingly, SMARCA4 knockdown resulted in an overall decrease
(Wilcoxon rank-sum test; P = 3.7 × 106) in the overlapping TAD
boundary strength, as shown by plotting the boundary scores for
the overlapping and unique TAD boundaries for the shSMARCA4
and shSCRAM cells (Fig. 6F). Furthermore, to address whether
this decrease is related to SMARCA4 binding, we compared the
scores of the TAD boundaries that were either SMARCA4-bound
or not. We observed a significant decrease (Wilcoxon rank-sum
test; P = 0.003) of TAD boundary strength at borders that lacked
SMARCA4 binding (Fig. 6G).
CTCF is an important component of TAD boundaries. When
we intersected a previously published MCF-10A CTCF ChIP-seq
data set (Ross-Innes et al. 2011) with SMARCA4 peaks, 10% of all
SMARCA4 peaks and 12% of the SMARCA4 peaks that are located
on a TAD boundary directly overlapped with CTCF, implying a
crosstalk between SMARCA4 and CTCF at least for a subset of
bound genomic regions (Supplemental Fig. S8E,F). The intersec-
tion of these two factors increased by twofold when the vicinity
(±1 kb) of both SMARCA4 and CTCF peaks were considered. To as-
sess whether the effects of SMARCA4 on TAD boundaries result
from changes in the local chromatin structure around the CTCF
sites, we analyzed publicly available SMARCA4-dependent accessi-
bility and nucleosome positioning DNase I- and MNase-seq data
sets (Tolstorukov et al. 2013; Morris et al. 2014; Stavreva et al.
2015). SMARCA4 perturbation affected nucleosome positioning
within hundreds of base pairs of CTCF binding sites in mouse fi-
broblast cells (Supplemental Fig. S9A–C), showing decreased nu-
cleosome occupancy immediately around the CTCF binding
sites. SMARCA4 perturbation also altered chromatin accessibility
inmurine epithelial cells (Supplemental Fig. S9D). Taken together,
these results demonstrate a role for SMARCA4, likely viamediating
the local chromatin accessibility around the CTCF sites.
Discussion
Modification of the chromatin structure by ATP-dependent re-
modeling complexes is an essential process in transcriptional reg-
ulation. SMARCA4 affects both the activation and repression of
many genes through its interactions with transcription factors
and other cofactors (Trotter and Archer 2008). To understand the
role of SMARCA4 in genome architecture, we characterized the
SMARCA4-dependent alterations in gene expression and higher-
order chromatin structure in mammary epithelial MCF-10A cells.
RNA-seq analysis in the control and SMARCA4 knockdown cells
showed an extensive down-regulation of genes related to ECM
components and up-regulation of genes related to lipid metabo-
lism and calcium signaling (Fig. 1). SMARCA4 is linked to calcium
signaling (Lai et al. 2009; Nasipak et al. 2015). Literature also sup-
ports the idea that SMARCA4 (or the mammalian SWI/SNF com-
plex) regulates lipid metabolism, as it was shown that SMARCA4
regulates PPARG expression, which in turn regulates lipid metabo-
lism in differentiating adipocytes (Salma et al. 2004). In addition,
SMARCD3, a subunit of the mammalian SWI/SNF complex, is re-
quired for activation of fatty acid and triglyceride synthesis in re-
sponse to insulin and to feeding in liver (Wang et al. 2013).
Interestingly, SMARCA4 binding was enriched at down-regulated
genes. The up-regulation of genes could be an indirect effect of
SMARCA4 knockdown, because in many cases, these genes were
not directly bound by SMARCA4 (Fig. 2E).
Growing evidence suggests that the shape of the nucleus, the
stiffest organelle in the cell, might partly be affected by force-in-
duced changes, a phenomenon known as nuclear mechanotrans-
duction (Dahl et al. 2008). It is becoming well established that the
cell surface adhesion receptors, such as integrins and cadherins,
can exert mechanical forces to the nucleus and can potentially
cause gene activation and/or chromatin reorganization (Wang
et al. 2009). However, changes in nuclear shape can be induced
from either external forces exerted by the cytoskeleton or via inter-
nal nuclear forces. Previous work showed that SMARCA4 knock-
down results in nuclear shape alterations in MCF-10A cells
(Imbalzano et al. 2013b). However, the disruption of the cytoplas-
mic filaments (actin, tubulin, and cytokeratins) did not alter
SMARCA4-dependent structural changes observed in the MCF-
10A cells (Imbalzano et al. 2013b). This implies that SMARCA4,
apart from its chromatin remodeling function, might have addi-
tional roles in maintaining the structural integrity of the nucleus
(Imbalzano et al. 2013a). Interestingly, in the present study, we de-
termined that many of the genes that are down-regulated follow-
ing SMARCA4 knockdown were associated with the extracellular
matrix. These findings suggest an additional mechanism for
SMARCA4-mediated regulation of nuclear integrity via regulation
of ECM genes and possible alteration of cell surface connections
and mechanotransducing forces to the nucleus.
Hi-C analysis of SMARCA4 knockdown and control MCF-10A
cells revealed a significant enrichment of subtelomeric interac-
tions in the shSMARCA4 cells (Fig. 4F–I). Literature evidence con-
necting SWI/SNF enzymes and telomeres is limited. SMARCA4
knockdown was shown to result in increased telomerase ex-
pression that leads to increased telomere lengths (Wu et al.
2014). Yeast SWI/SNF is required for telomeric silencing (Dror
and Winston 2004), and telomeric expansion (Tomar et al.
2008). Mammalian cells lacking SMARCAL1, which is a SNF2 fam-
ily ATPase but is not a subunit of the mammalian SWI/SNF com-
plex, accumulate elevated levels of telomere-associated DNA
damage (Poole et al. 2015). Moreover, knockdown of the mamma-
lian SWI/SNF enzyme subunit, ARID1A, reduces telomeric repeat-
containing RNA (TERRA) levels by at least twofold (Scheibe et al.
2013). Further experiments assessing whether SMARCA4 affects
nucleosome positioning at or enhances/interferes with binding
of specific proteins at telomeres to affect higher-order telomeric
structures will shed further light on the relationship between
SMARCA4 and telomere organization. Recently, Guidi et al.
(2015) showed that the telomeres of yeast cells undergo spatial re-
organization upon switching to different metabolic states.
Because our RNA-seq analysis showed up-regulation of genes re-
lated to lipid synthesis and since our Hi-C analysis showed alter-
ations in telomeric interactions in shSMARCA4 cells, it is
tempting to speculate that the increased telomeric interactions
(Fig. 4F–I) may be associated with changes in the metabolic state
of the shSMARCA4 cells.
The importance of nuclear structure–gene expression rela-
tionships is supported by our finding that 4%of genomic compart-
ments are altered in a SMARCA4-dependent manner (Fig. 4B). The
magnitude of the functional impact of SMARCA4 on the architec-
tural landscape is illustrated by previous reports showing that com-
parisons of relative compartmental differences in distinct cell
types ranged from 4% to 25% of the genome (Barutcu et al.
2015; Dixon et al. 2015). The compartmental changes are associat-
ed with gene expression (Fig. 5C). However, it is still debated
whether compartmental change or chromosomalmovement caus-
es differential gene expression or vice versa. There is evidence sup-
porting both viewpoints (Chuang and Belmont 2007; Therizols
et al. 2014).
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The formation of topologically associating domain boundar-
ies is dependent onmany factors (Van Bortle et al. 2014; Cubeñas-
Potts and Corces 2015), especially insulators such as CTCF and
cohesin. Here, we report the rather remarkable observation that
SMARCA4 peaks and super-enhancers were also enriched at TAD
boundaries (Fig. 6D,E), and the depletion of SMARCA4 resulted
in ∼14% of TAD boundaries being altered and lower TAD boun-
dary scores genome-wide (Fig. 6F). Furthermore, SMARCA4-bound
boundaries exhibited a stronger boundary score than the boundar-
ies not bound by SMARCA4 (Fig. 6G). Therefore, in addition
to well-studied insulators such as CTCF and cohesin, maintenance
of TAD boundaries is affected, directly or indirectly, by SMARCA4,
and by extension, the mammalian SWI/SNF enzyme possibly via
regulating CTCF and cohesin binding. A previous report showed
that SMARCA4 and other subunits of the mammalian SWI/SNF
complex bind near regions critical for genome organization (e.g.,
CTCF and lamin binding sites and DNA replication origins)
(Euskirchen et al. 2011). Our analysis of publicly available
(Tolstorukov et al. 2013; Morris et al. 2014) DNase I accessibility
and nucleosome positioning data around the CTCF sites demon-
strated a SMARCA4-dependent effect on local chromatin structure
(Supplemental Fig. S9), similar to the effect of SMARCA4 knock-
down that was previously noted around TSS of known genes
(Tolstorukov et al. 2013). Further experiments investigating
whether SMARCA4 is required for CTCF, as well as cohesin and
mediator binding, would provide insight into the mechanism by
which SMARCA4 affects TAD boundaries.
Despite affecting genome organization at multiple levels, the
overall genome organizationwas largely preserved upon SMARCA4
knockdown. Recent studies knocking down other fundamental
chromatin organizers, CTCF (Zuin et al. 2014), cohesin (Seitan
et al. 2013), and histone H1 (Geeven et al. 2015) similarly showed
little effect on overall genome organization as assayed byHi-C. It is
possible that the remaining SMARCA4 levels in the knockdown
MCF-10A cells (Fig. 1A) resulted inmoremodest changes than oth-
erwise might have been expected. It is also likely that there are re-
dundant molecular mechanisms in the cell to ensure the integrity
of the genome and the nucleus. In the shSMARCA4MCF-10A cells,
the SMARCA4 homolog SMARCA2 (also known as BRM) still
exists, and we previously reported that MCF-10A cells are not via-
ble when both SMARCA4 and SMARCA2 are simultaneously
knocked down (Cohet et al. 2010). Total removal of SMARCA4
by CRISPR/Cas9 in the MDA-MB-231 human metastatic breast
cancer cell line and genetic ablation in primary myoblasts also re-
sulted in cell death (Padilla-Benavides et al. 2015; Wu et al. 2015).
These findings suggest that the importance of SMARCA4 in cell vi-
ability may preclude observing more severe effects on genome
organization.
Taken together, we identify novel roles for SMARCA4 in reg-
ulating higher-order chromatin structure by affecting telomere or-
ganization, TAD boundary strength, and the frequency and
specificity of long-range chromatin interactions.
Methods
Cell culture
MCF-10A cells expressing control shRNA and shRNA targeting
SMARCA4 were generated as previously described (Cohet et al.
2010). The cells were maintained in monolayer in Dulbecco’s
modified Eagle’s medium-F12 (DMEM/F12) (Invitrogen,
21041025) supplemented with 5% horse serum (Invitrogen,
16050122), 1% penicillin/streptomycin (Invitrogen, 15140122),
0.5 µg/mL hydrocortisone (Sigma, H-0888), 100 ng/mL cholera
toxin (Sigma, C-8052), 10 µg/mL insulin (Sigma, I-1882), and 20
ng/mL recombinant human EGF (Peprotech, 100–15) as described
previously (Debnath et al. 2003). The doxycyline induction was
performed by the addition of 0.05 µg/mL doxycycline to the cells
and incubating them for 3–4 d.
RNA-seq and analysis
RNA was isolated from MCF-10A cells at ∼75% confluence using
the TRIzol Reagent (Life Technologies #15596-026), including
treatment with DNase I. The poly(A)-selected RNA-seq libraries
were generated with TruSeq RNA Sample Preparation Kit v2, and
single-end 100-bp sequencing was performed using a HiSeq 2000
instrument. RNA-seq analysis was performed by filtering andmap-
ping the reads by Bowtie 2 (Langmead and Salzberg 2012), quanti-
fying the transcripts by RSEM v1.2.7 (Li and Dewey 2011), and
finding the differentially expressed genes (log2 fold change>1, P
< 0.01) by DESeq2 (Love et al. 2014).
Preparation of Hi-C libraries
Hi-C was performed as previously described with minor modifica-
tions (Belton et al. 2012). Themodificationwas in the biotin incor-
poration step, in which the mixture was incubated for 40 min at
37°C. TheMCF-10A shSCRAM and shSMARCA4 samples displayed
a range of 25%–50% biotin incorporation efficiency. At the end of
Hi-C sample preparation, the libraries were sequenced using
paired-end 100-bp reads with a HiSeq 2000 instrument.
Read mapping/binning/ICE correction
Supplemental Table S3 summarizes themapping results and differ-
ent classes of reads and interactions observed (Lajoie et al. 2015).
The data were binned at 2.5 Mb, 1 Mb, 250 kb, 100 kb, and
40 kb nonoverlapping genomic intervals. In our Hi-C analyses,
we utilized the iterative correction and eigenvector decomposition
(ICE) method (Imakaev et al. 2012). The replicates showed high
correlation (Pearson correlation; R2 ranging from 0.69 to 0.92) at
multiple scales (Supplemental Fig. S4). For the downstream analy-
ses, sequences obtained from both biological replicates were
pooled and ICE-corrected to serve as a combined data set.
Z-score calculation
We calculated the Z-scores by modeling the overall Hi-C decay
with distance using a modified LOWESS method (α = 1%, IQR fil-
ter), as described previously (Sanyal et al. 2012). LOWESS calcu-
lates the weighted-average and weighted-standard deviation for
every genomic distance and therefore normalizes for genomic dis-
tance signal bias.
Calculation of differential interactions
To capture the differences between shSCRAM and shSMARCA4 in-
teractions, we used a method previously described (Barutcu et al.
2015). Briefly, we first transformed the Hi-C data into Z-score ma-
trices for all four replicate data sets (shSMARCA4-R1, shSMARCA4-
R2, shSCRAM-R1, and shSCRAM-R2). For each interaction,
the mean sample:sample (between samples) Z-score difference
was calculated from all pairwise combinations of the four data
sets (shSMARCA4-R1–shSCRAM-R1, shSMARCA4-R1–shSCRAM-
R2, shSMARCA4-R2–shSCRAM-R1, shSMARCA4-R2–shSCRAM-
R2). The replicate:replicate Z-score difference (within samples)
was also calculated for a random set of 500,000 interactions.
These random replicate:replicate Z-score differences were then
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used to build an expected distribution of Z-score differences.
The resulting Z-score difference matrix was then derived by calcu-
lating for each bin the ratio of the mean of the set of four possible
sample:sample Z-score differences minus the genome-wide mean
of the replicate:replicate Z-score difference, divided by the ge-
nome-wide standard error of the replicate:replicate Z-score differ-
ences. All statistical analyses have been corrected for multiple
correction tests.
Compartment profiles
To detect the genomic compartments, first, Pearson correlation of
the Z-score matrices was calculated. In performing principal com-
ponent analysis (Lieberman-Aiden et al. 2009; Zhang et al. 2012),
the first principal component detects the patterns of increased and
decreased interaction across the genome that appear as a plaid pat-
tern in the heatmap. Each genomic regionmatches this prominent
interaction pattern (positive eigenvector value) or its opposite
(negative eigenvector value), and these represent the two spatially
segregated compartments. The open, gene rich “A-type” compart-
mentmay end upwith either a positive or negative eigenvector. To
detect which compartment is the open “A-type” and which is the
closed “B-type,” the genome-wide gene density was calculated to
assign the “A-type” and “B-type” compartmentalization.
Identification of TAD boundaries (insulation square analysis)
TAD calling was performed as calculating the insulation score of
each bin using the 40-kb resolution combined Hi-C data as previ-
ously described (Barutcu et al. 2015; Crane et al. 2015).
ChIP-seq analysis
The ChIP assay was performed as previously described (Lee et al.
2006). The chromatin was sheared by using a Bioruptor instru-
ment on high setting, 30 sec on and 30 sec off, for 5 min for five
cycles. The pull-down was performed using a SMARCA4 antibody
(Santa Cruz #G-7). The pull-down and input control sequencing li-
braries were generated using the NEXTflex Rapid DNA Sequencing
Kit (Bioo Scientific #5144-02) and were sequenced by using single-
end 100-bp readswith aHiSeq 2000 instrument. The adapterswere
trimmed from the sequencing reads, and the reads were aligned
to the hg19 human genome using the Bowtie 2 tool (Langmead
and Salzberg 2012). Quality controls, peak calling, motif analysis
and peak annotation were performed using the HOMER suite
(Heinz et al. 2010). As the ChIP signal across the biological repli-
cates showed high correlation (Pearson correlation;, R2 = 0.72)
(Supplemental Fig. S3B), we performed ChIP-seq peak calling on
the pooled replicates.
DNA fluorescence in situ hybridization (FISH)
FISH was performed as described previously (Sehgal et al. 2016) on
MCF-10A cells induced to express either shSCRAM or shSMARCA4
shRNAs. Probes from bacterial artificial chromosomes RP11-
82D16 for Chr 1p, RP11-81J5 for Chr 1q, RP11-81L5 for Chr 4p;
and RP11-196K19 for Chr 4q were used. shRNA expression was
confirmed via GFP expression and by immunofluorescence for
SMARCA4. Cell images were acquired using an epifluorescence
Zeiss AxioImager microscope equipped with a Hamamatsu
charged coupled device (CCD) camera in a series of stacked images
(n, shSCRAMChr 1, 108; shSMARCA4Chr 1, 102; shSCRAMChr 4,
82; shSMARCA4 Chr 4, 100). Images were captured using 100× ob-
jective magnification and Zen 2011 imaging software (Zeiss).
Image J’s coordinate function was used to identify 3D coordinates
of probes and subsequently run through the eFISHent program for
distance measurements (Fritz et al. 2014).
Data access
The raw and processed RNA-seq, ChIP-seq, andHi-C data sets from
this study have been submitted to the NCBI Gene Expression
Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) under acces-
sion number GSE74716.
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